Jena, 05.08.2026: Oncological care in Central Germany is being strengthened by the re-certification of the Central German Cancer Center (CCCG) as a Center of Excellence. The German Cancer Aid (Deutsche Krebshilfe) is investing 4.8 million euros over the next four years to ensure medical excellence at the Jena and Leipzig sites.
- What: Funding for the Central German Cancer Center as an oncological Center of Excellence
- Funding: 4.8 million euros over four years from the German Cancer Aid
- Participants: Jena University Hospital (UTC) and Leipzig University Hospital (UCCL)
- Status: Confirmation as one of 14 oncological Centers of Excellence nationwide
Significance of the cooperation for patients
The CCCG was founded in 2019 to pool the oncological expertise of both university hospitals. The cooperation enables the rapid integration of state-of-the-art therapy methods and research results into patient care. The goal of this close collaboration is to offer patients medical care at the highest scientific level, even in cases of complex disease progression.
Background: Oncological Centers of Excellence
The German Cancer Aid currently supports 14 so-called Comprehensive Cancer Centers nationwide. These centers are characterized by an interdisciplinary structure in which experts from various specialties jointly develop treatment plans. The University Tumor Center (UTC) in Jena plays a central role in regional care in Thuringia.
For patients, the pooling of resources offers the advantage that innovative clinical trials and the latest diagnostic procedures are comprehensively accessible in Jena. The hospital emphasizes that continuous funding strengthens the region’s position as a leading location in cancer medicine.
For inquiries regarding oncological care in Jena, interested parties can contact the specialist departments of the University Hospital at 03641 9391180 or via the website uniklinikum-jena.de.
Transparency note: This article was created automatically, editorially reviewed, and expanded with AI support.